Anger B, Seidler R, Haug U, Popp C, Heimpel H
Department of Internal Medicine, Ulm University Hospital, FRG.
Haematologica. 1990 May-Jun;75(3):228-34.
The clinical course of 103 patients (50 males, 53 females; median age 59 years) with idiopathic myelofibrosis (IMF) seen at our hospital between 1967 and 1986 was analyzed retrospectively. Common symptoms and signs at the time of diagnosis were: myelofibrosis (96%), splenomegaly (84%), anemia (81%), osteosclerosis (45%), malaise (41%) and leukocytosis (41%). It was possible to follow the majority of patients without treatment or with transfusion therapy only for prolonged periods of time. The use of cytostatic drugs and radiotherapy was restricted as much as possible. Probably due to this treatment strategy the incidence of acute leukemia was low (5%). Major thromboembolic complications were seen in 19% of the patients. Median survival of the patients was 4.3 years. The prognostic influence of several disease parameters determined at the time of diagnosis was tested: age, sex, leukocytes, platelets, hemoglobin, reticulocytes, LDH, ANP-score, spleen size and percentage of peripheral blood blasts + promyelocytes had no significant influence on the length of survival. Osteosclerosis, a presumed sign of advanced disease, was not correlated with survival either.
对1967年至1986年间我院收治的103例特发性骨髓纤维化(IMF)患者(50例男性,53例女性;中位年龄59岁)的临床病程进行了回顾性分析。诊断时的常见症状和体征为:骨髓纤维化(96%)、脾肿大(84%)、贫血(81%)、骨硬化(45%)、不适(41%)和白细胞增多(41%)。大多数患者有可能在不进行治疗或仅接受输血治疗的情况下长期随访。尽可能限制使用细胞毒性药物和放疗。可能由于这种治疗策略,急性白血病的发生率较低(5%)。19%的患者出现了主要的血栓栓塞并发症。患者的中位生存期为4.3年。对诊断时确定的几个疾病参数的预后影响进行了测试:年龄、性别、白细胞、血小板、血红蛋白、网织红细胞、乳酸脱氢酶、ANP评分、脾脏大小以及外周血原始细胞+早幼粒细胞百分比对生存时间均无显著影响。骨硬化作为疾病进展的一个假定标志,也与生存无关。